ATG 5 down-regulation decreases human A53T ASYN-induced death in rat cortical neurons. by Maria Xilouri (264240)

Selection for West Nile virus populations with decreased susceptibility to ribavirin. by Greta A. Van Slyke (761322)

Percentage decreases in scores of self-reported health, large muscle function, and mobility by chronic diseases per wave after disease incidence. by James Davis (2267599)

ROS and superoxide decrease in the dormant form of mycobacteria. by Amar Yeware (7115063)

Rg3 decreases HDAC3 expression. by Xiu Shan (62157)

Klotho decreased the expression of CHOP in mouse heart. by Shuang Song (457799)

Calpeptin treatment decreases cell density and proliferation. by Daniela M. Santos (211055)

Chemical Inhibition of eEF1A-1 Peptide Elongation Activity Decreases Palmitate-Induced Cell Death. by Alexandra M. Stoianov (759321)

Cortactin knockdown results in decreased FA turnover. by Alok Tomar (139282)

Diabetic kidney shows decreased klotho expression. by Jeong Suk Kang (7359572)

“…<p>(a) Representative images of the kidney from normal and diabetic biopsies showing the decreased klotho expression in diabetic podocytes by IHC. …”

Tranilast decreases OC formation induced by RANKL. by Tien Van Phan (583324)

Tranilast decreases RANKL-induced ROS level. by Tien Van Phan (583324)

Microglia-conditioned medium decreases NPC viability. by Johanna Mäkelä (223358)

Hypothesis that explains and predicts expansion of ages of KD due to decreased IgG levels. by Hiromi Yamaguchi (2396248)

A2EN supernatants do not decrease cell-free HIV viability. by Lyndsey R. Buckner (843006)

In the null model the event rate does not decrease as a function of the inverse of time. by Thomas O. Richardson (251876)

Incubation of <i>T</i>. <i>brucei</i> with Pol I transcription inhibitors results in a dramatic decrease in VEX1 foci. by Louise E. Kerry (3815164)

AGE-modification of laminin leads to a decrease in Kir4.1 function. by Kayla Thompson (4885036)

PV1-treated mice exhibited a decrease in overall activation of T lymphocytes. by Pedro Henrique Papotto (791904)

Galiellalactone decreases the proportion of ALDH+ prostate cancer cells in vitro and the ALDH1A1 expression in vivo. by Rebecka Hellsten (348459)

“…The proportion of ALDH+ cells is expressed as mean ± SEM (n = 2–4). The proportion of ALDH+ DU145 cells were significantly decreased by galiellalactone at the concentrations 10 µM (p = 0.0060), 25 µM (p = 0,0013) and 50 µM galiellalactone (p<0,0001). …”